ask="38.66"
ask_size="100"
average_daily_volume="1427790"
bid="38.12"
bid_size="100"
book_value="11.83"
change="-3.38"
change_from_200_day_moving_average="-16.97"
change_from_50_day_moving_average="-3.44"
change_from_52_week_high="-41.97"
change_From_52_week_low="6.84"
change_in_percent="-8.12%"
close="38.22"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="41.10"
high_52_weeks="80.19"
last_trade_date="1/17/2017"
last_trade_price="38.22"
last_trade_size="57368"
last_trade_time="4:00pm"
low="37.98"
low_52_weeks="31.38"
market_capitalization="3.28B"
moving_average_200_day="55.19"
moving_average_50_day="41.66"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.36"
open="41.05"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="-30.75%"
percent_change_from_50_day_moving_average="-8.25%"
percent_change_from_52_week_high="-52.34%"
percent_change_from_52_week_low="+21.80%"
previous_close="41.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.52"
price_per_sales="95.82"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="1398902"
weeks_range_52="31.38 - 80.19"
